Magnolol and honokiol enhance HL-60 human leukemia cell differentiation induced by 1,25-dihydroxyvitamin D ₃ and retinoic acid

Keyphrases

• HL-60 Cells 100%
• Retinoic Acid 100%
• Cell Differentiation 100%
• Magnolol 100%
• 1,25-dihydroxyvitamin D3 100%
• Human Leukemia Cells 100%
• Honokiol 100%
• All-trans Retinoic Acid 62%
• CD14 25%
• CD11b 25%
• Acid Treatment 12%
• Medicinal Plants 12%
• SB203580 12%
• Inhibitory Effect 12%
• JNK Inhibitor 12%
• JNK Pathway 12%
• Cell Population 12%
• SP600125 12%
• Pharmacological Studies 12%
• Antioxidant Properties 12%
• P38 MAPK Pathway 12%
• G(0) 12%
• Magnolia Officinalis 12%
• Differentiation Markers 12%
• Lignans 12%
• Enhancing Agents 12%
• Cyclin-dependent Kinase Inhibitor 12%
• MAPK Inhibitors 12%
• Acute Promyelocytic Leukemia 12%
• HL-60 Cell Differentiation 12%
• Retinoic Acid-induced Differentiation 12%
• P27Kip1 12%
• PD098059 12%
• MEK Inhibitor (MEKi) 12%
• MEK Pathway 12%

Pharmacology, Toxicology and Pharmaceutical Science

• Leukemia 100%
• Magnolol 100%
• Retinoic Acid 100%
• Honokiol 100%
• Medicinal Plant 12%
• 2 (2 Amino 3 Methoxyphenyl)chromone 12%
• SB 203580 12%
• Stress Activated Protein Kinase Inhibitor 12%
• Anti-Inflammatory Drug 12%
• Antioxidant 12%
• anthra[1,9 Cd]pyrazol 6(2h) One 12%
• Lignan 12%
• Mitogen Activated Protein Kinase Kinase Inhibitor 12%
• Magnolia Officinalis 12%
• Cyclin Dependent Kinase Inhibitor 12%
• Promyelocytic Leukemia 12%

Biochemistry, Genetics and Molecular Biology

• Tretinoin 100%
• Retinoic Acid 100%
• Cellular Differentiation 100%
• Honokiol 100%
• Low Drug Dose 25%
• CD14 25%
• P38 Mitogen-Activated Protein Kinases 25%
• Medicinal Plant 12%
• Cyclin-Dependent Kinase 12%
• MEK Inhibitor 12%
• Magnolia Officinalis 12%